First Washington CORP

First Washington CORP is a registered investment advisor headquartered in Seattle, Washington, specializing in small-cap and mid-cap equity investing within the Pacific Northwest's innovation-driven financial ecosystem. The firm files with the SEC under CIK #0001390043, with a CIK assignment from the late 2000s indicating approximately fifteen years of SEC-registered operations—a filing tenure encompassing the late stages of the financial crisis recovery, the subsequent extended bull market, and recent market dislocations including the pandemic and rate-driven corrections. The "First Washington" name establishes direct connection to the firm's Pacific Northwest heritage, grounding the practice within Washington State's distinctive economic identity. Seattle's evolution into a global technology and innovation hub—anchored by Amazon, Microsoft, Boeing, and a thriving startup ecosystem—creates a natural environment for growth-oriented investment managers with particular expertise in identifying emerging companies with substantial expansion potential. Seattle's position as a West Coast financial center provides access to both institutional capital and a sophisticated client base of technology executives, entrepreneurs, and corporate professionals whose wealth generation often derives from early-stage or rapid-growth company participation. This regional context presumably informs First Washington's analytical perspective on growth company evaluation, where proximity to Pacific Northwest technology and innovation ecosystems provides firsthand understanding of emerging business models and competitive dynamics. Through 13F Portfolio Composition analysis, observers can examine First Washington's disclosed equity holdings across its multi-year filing history and assess how the firm's small-mid cap growth specialization manifests in sector positioning, market capitalization focus, and security selection within the less efficient segments of American equity markets.

First Washington CORP employs a small-mid cap growth investment philosophy, targeting emerging and rapidly expanding companies across technology, healthcare, industrials, and consumer sectors before they achieve the scale and analyst coverage characterizing large-cap equities. This market capitalization niche exploits informational inefficiencies that persist in less-followed segments of equity markets, where dedicated research effort can identify underappreciated growth trajectories invisible to analysts focused on large-cap coverage universes. The investment process emphasizes fundamental research identifying companies at inflection points—businesses demonstrating accelerating revenue growth, expanding addressable markets, improving competitive positioning, or approaching profitability transitions that may drive meaningful share price appreciation. Small-mid cap growth investing requires analytical capabilities spanning emerging technology evaluation, market sizing, management assessment, and competitive landscape analysis in rapidly evolving industries. Technology exposure captures Pacific Northwest innovation themes and broader digital economy growth drivers, with the firm's Seattle base providing natural proximity to technology company headquarters, industry conferences, and the regional venture capital community that feeds the small-cap growth pipeline. Healthcare positions target emerging biotechnology, medical device, and healthcare services companies where innovation creates substantial growth potential. Industrial holdings capture manufacturing innovation and niche market leaders, while consumer positions focus on brands and services experiencing rapid market share gains. Small-mid cap specialization creates opportunity through market structure advantages: companies below typical institutional coverage thresholds receive minimal analyst attention, enabling research-intensive managers to develop differentiated insights unavailable in efficient large-cap markets. However, this same inefficiency introduces liquidity constraints requiring patient position building and unwinding. Low-to-moderate turnover characteristics observable through sequential 13F filings demonstrate patient holding periods allowing growth theses to develop over multi-year timeframes. The Sector Allocation History derived from over fifteen years of 13F tracking reveals how the firm navigates evolving growth opportunities across sectors as technology development, healthcare innovation, and industrial transformation create new small-mid cap investment candidates.

First Washington CORP represents a Seattle-based small-mid cap growth specialist applying dedicated research expertise to the less efficient segments of American equity markets. The firm's Pacific Northwest headquarters provides natural proximity to technology innovation ecosystems that feed the small-cap growth pipeline, while approximately fifteen years of 13F filing history provides meaningful longitudinal data for evaluating investment approach across multiple market cycles. Key characteristics observable from disclosed filings include concentrated small-mid cap positioning across technology, healthcare, industrials, and consumer sectors, growth-oriented security selection targeting companies at inflection points, and low-to-moderate turnover reflecting patient holding periods allowing growth theses to compound. The Annualized Return (CAGR) derived from simulating disclosed positions across approximately fifteen years captures the small-mid cap growth strategy's capital trajectory through varying market environments—including periods of small-cap outperformance and underperformance relative to large-cap indices. The Sharpe Ratio provides essential risk-adjusted context for evaluating whether small-mid cap growth exposure generates sufficient alpha to compensate for dramatically elevated volatility relative to large-cap alternatives. For allocators comparing active small-mid cap managers, this efficiency metric informs whether First Washington's research-intensive approach delivers measurably superior risk-adjusted outcomes compared to passive small-cap indices or diversified growth strategies. Seattle's innovation ecosystem—encompassing technology, cloud computing, artificial intelligence, and healthcare—provides analytical context supporting growth company evaluation. Proximity to emerging business models and technology trends potentially creates informational advantages in assessing small-cap growth candidates proximate to the Pacific Northwest's technology corridors. The Top 10 Holdings Concentration metric reveals portfolio construction across the small-mid cap universe, indicating the balance between diversification across numerous smaller positions and concentration in highest-conviction growth opportunities. For institutional allocators seeking dedicated small-mid cap exposure, platform-based 13F tracking provides ongoing visibility into the firm's market capitalization focus, sector emphasis, and growth positioning. As small-cap markets face structural evolution—including declining public company counts, private equity competition for attractive growth businesses, and evolving market microstructure affecting small-cap liquidity—how might First Washington's research-intensive approach navigate an environment where the small-cap opportunity set has contracted even as competition from passive vehicles and quantitative strategies has intensified within this historically inefficient market segment?

The risk characteristics of First Washington's disclosed portfolio reflect its small-mid cap growth concentration, producing a higher-volatility profile inherently distinct from diversified large-cap strategies. Small-cap and mid-cap equities historically exhibit elevated volatility compared to large-cap counterparts, driven by lower liquidity, less diversified business models, higher operational leverage, and greater sensitivity to economic cycle fluctuations. Analysis of Max Drawdown Depth through historical simulation of disclosed positions—leveraging the firm's approximately fifteen years of 13F filing history—quantifies portfolio behavior during market stress episodes. Small-cap growth stocks typically experience amplified drawdowns during risk-off environments when investors flee toward large-cap quality and liquidity. The 2020 pandemic crash, which initially devastated small-cap equities before producing extraordinary recoveries, provides particularly instructive context for understanding the small-mid cap growth strategy's drawdown and recovery characteristics. The Volatility Profile derived from 13F replication reveals fluctuation characteristics substantially exceeding broad market and large-cap benchmarks. Small-mid cap growth portfolios typically exhibit beta significantly above unity, with pronounced sensitivity to economic growth expectations, risk appetite, and liquidity conditions. Individual positions may experience dramatic price movements on earnings reports or product announcements, as smaller companies have less diversified revenue streams to cushion single-event impacts. Liquidity risk represents a permanent feature of small-mid cap investing. Positions in less liquid securities may be difficult to exit during market stress without meaningful price impact, potentially amplifying drawdowns beyond what mark-to-market volatility alone would suggest. Portfolio construction must calibrate position sizes against available trading liquidity to manage this structural constraint. Growth stock sensitivity to interest rate movements adds additional risk dimension, as higher discount rates mathematically compress the present value of distant future earnings that growth stock valuations depend upon. The 2022 rate-driven correction demonstrated this dynamic with particular severity for smaller growth companies whose profitability remained distant. The Downside Capture Ratio provides quantitative perspective on small-mid cap growth portfolio behavior during declining markets.